Clinical trials for Covid-19 treatment
A recent pilot study in China, in which seven Covid-19 patients received intravenous infusions of mesenchymal stem cells, indicates that the intervention was safe and that the approach may improve patient outcomes.
Partagez sur vos réseaux sociaux
Write a comment